News from BC FORUM - recirculated from the Canadian Deprescribing Network website November, 2016 The Canadian Deprescribing Network Visit the website here for more information. November, 2016 - The Canadian Deprescribing Network (CaDeN) is a group of individuals who are committed to improving the health of Canadians by reducing the use of potentially inappropriate medicines and enhancing access to non-drug alternatives. Funded primarily through a CIHR Partnership for Health System Improvement grant, CaDeN members represent a wide range of perspectives related to deprescribing, including patient advocates, health care professionals, academic researchers, and other health care leaders with experience in the pharmaceutical field. Each member contributes toward the overarching goal of reducing the use of inappropriate medicines, leveraging their skills and knowledge to help with a variety of initiatives. Ultimately, CaDeN seeks to build capacity and catalyze action to promote deprescribing all across Canada. The first National Stakeholder’s meeting for CaDeN was held in January 2015, followed by the 2nd annual meeting in January 2016. CaDeN is currently composed of a core working group, and 5 sub-committees. Each is working toward two overarching goals: • Reduce harm by curbing the prescription of inappropriate medications by 50% by 2020 • Promote health by ensuring access to safer pharmacological or non-pharmacological therapies CaDeN’s Action Plan is being rolled out and evaluated over a 4-year time period: | 
